Source
Katayama K et al., “A pentapeptide from type I procollagen promotes extracellular matrix production”
Quick Summary
The foundational mechanism paper for the Pal-KTTKS / Matrixyl pentapeptide story. Katayama and colleagues report on a pentapeptide fragment derived from type I procollagen that, in laboratory study, signals connective-tissue cells to produce more extracellular-matrix proteins. The paper underlies the cosmetic-industry framing of the Matrixyl pentapeptide as a "signaling" peptide.
| Source type | peer_reviewed |
|---|
What Studied
The paper reports a laboratory investigation of a small peptide fragment (KTTKS) derived from the C-terminal propeptide of type I procollagen. The researchers tested whether the pentapeptide could signal cultured fibroblasts to upregulate extracellular-matrix protein production, including collagen-family proteins and fibronectin.
Main Findings
The published findings indicate that the pentapeptide acts as a signal for fibroblasts to increase synthesis of collagen-family proteins and fibronectin in the studied culture system. This is the mechanism paper that the cosmetic industry later used as the rationale for marketing the palmitoyl-conjugated form (Pal-KTTKS, Matrixyl) as a topical cosmetic-appearance ingredient.
Why It Matters
For a Question explaining how Matrixyl works at the cosmetic-appearance layer, this source is the upstream mechanism reference. It is important to cite carefully: the paper is a laboratory study of a peptide fragment, not a clinical efficacy study of a topical cosmetic. The Question must therefore frame mechanism at the cosmetic-appearance layer and lean on the human cosmetic-appearance studies (Robinson, Schagen, Lupo & Cole) for the visible-look claim.
Original Source
AI Tool Box
Structured page facts at a glance.
- Source
- Katayama K et al., “A pentapeptide from type I procollagen promotes extracellular matrix production”
- Quick Summary
- The foundational mechanism paper for the Pal-KTTKS / Matrixyl pentapeptide story. Katayama and colleagues report on a pentapeptide fragment derived from type I procollagen that, in laboratory study, signals connective-tissue cells to produce more extracellular-matrix proteins. The paper underlies the cosmetic-industry framing of the Matrixyl pentapeptide as a "signaling" peptide.
- What Studied
- The paper reports a laboratory investigation of a small peptide fragment (KTTKS) derived from the C-terminal propeptide of type I procollagen. The researchers tested whether the pentapeptide could signal cultured fibroblasts to upregulate extracellular-matrix protein production, including collagen-family proteins and fibronectin.
- Main Findings
- The published findings indicate that the pentapeptide acts as a signal for fibroblasts to increase synthesis of collagen-family proteins and fibronectin in the studied culture system. This is the mechanism paper that the cosmetic industry later used as the rationale for marketing the palmitoyl-conjugated form (Pal-KTTKS, Matrixyl) as a topical cosmetic-appearance ingredient.
- Why It Matters
- For a Question explaining how Matrixyl works at the cosmetic-appearance layer, this source is the upstream mechanism reference. It is important to cite carefully: the paper is a laboratory study of a peptide fragment, not a clinical efficacy study of a topical cosmetic. The Question must therefore frame mechanism at the cosmetic-appearance layer and lean on the human cosmetic-appearance studies (Robinson, Schagen, Lupo & Cole) for the visible-look claim.
- Supports
- question_what-does-matrixyl-do-for-skin, ingredient_matrixyl